IMIDS FOUNDATION Trademark

Trademark Overview


On Monday, August 21, 2017, a trademark application was filed for IMIDS FOUNDATION with the United States Patent and Trademark Office. The USPTO has given the IMIDS FOUNDATION trademark a serial number of 87576884. The federal status of this trademark filing is REGISTERED as of Tuesday, August 14, 2018. This trademark is owned by Celgene Corporation. The IMIDS FOUNDATION trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceutical preparations for use in the treatment of cancer and immune related diseases; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system

Providing on-line information in the field of diagnosis and treatment of cancer; providing an on-line computer database featuring information relating to diagnosis and treatment of cancer; providing medical information services; providing links to web sites of others featuring information about the diagnosis and treatment of cancer; providing medical information and pharmaceutical information services, namely, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; providing pharmacogenetic testing, predictive medical testing, personalized medical testing, gene sequencing-based testing and genotyping, all for medical diagnostic and treatment purposes, based on the assessment, development and application of genomic discoveries in the pharmaceutical, informatics and clinical diagnostic industries

Development and testing services in the fields of biotechnology, chemistry and pharmaceuticals; scientific study and research in the fields of the prevention, treatment and management of illness, health care delivery and the scientific aspects of health care policy, health care cost management and financing as these fields impact on quality of health care; research in the fields of chemicals and pharmaceuticals; research and testing services in the fields of chemicals and pharmaceuticals; research and development of new products for others in the fields of chemicals and pharmaceuticals; providing clinical laboratory testing services for medical and scientific research and development purposes, namely, pharmacogenetic testing, predictive medical testing, personalized medical testing, gene sequencing-based testing and genotyping based on the assessment, development and application of genomic discoveries in the pharmaceutical, informatics and clinical diagnostic industries; scientific res...
imids foundation

General Information


Serial Number87576884
Word MarkIMIDS FOUNDATION
Filing DateMonday, August 21, 2017
Status700 - REGISTERED
Status DateTuesday, August 14, 2018
Registration Number5538768
Registration DateTuesday, August 14, 2018
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 29, 2018

Trademark Statements


Goods and ServicesPharmaceutical preparations for use in the treatment of cancer and immune related diseases; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system
Section 2(f) Limitation StatementAs to "IMIDS"
Goods and ServicesProviding on-line information in the field of diagnosis and treatment of cancer; providing an on-line computer database featuring information relating to diagnosis and treatment of cancer; providing medical information services; providing links to web sites of others featuring information about the diagnosis and treatment of cancer; providing medical information and pharmaceutical information services, namely, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; providing pharmacogenetic testing, predictive medical testing, personalized medical testing, gene sequencing-based testing and genotyping, all for medical diagnostic and treatment purposes, based on the assessment, development and application of genomic discoveries in the pharmaceutical, informatics and clinical diagnostic industries
Disclaimer with Predetermined Text"FOUNDATION"
Goods and ServicesDevelopment and testing services in the fields of biotechnology, chemistry and pharmaceuticals; scientific study and research in the fields of the prevention, treatment and management of illness, health care delivery and the scientific aspects of health care policy, health care cost management and financing as these fields impact on quality of health care; research in the fields of chemicals and pharmaceuticals; research and testing services in the fields of chemicals and pharmaceuticals; research and development of new products for others in the fields of chemicals and pharmaceuticals; providing clinical laboratory testing services for medical and scientific research and development purposes, namely, pharmacogenetic testing, predictive medical testing, personalized medical testing, gene sequencing-based testing and genotyping based on the assessment, development and application of genomic discoveries in the pharmaceutical, informatics and clinical diagnostic industries; scientific research services; scientific research, namely, development of pharmaceuticals or diagnostic methods for others; providing an interactive website featuring technology that enables users to enter, access, track, monitor and generate health and medical information and reports

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, August 25, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, August 25, 2017
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, August 25, 2017
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCelgene Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901

Party NameCelgene Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901

Party NameCelgene Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901

Trademark Events


Event DateEvent Description
Monday, August 14, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, December 9, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, December 9, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, December 9, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, December 9, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, December 9, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, December 9, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, August 14, 2018REGISTERED-PRINCIPAL REGISTER
Tuesday, May 29, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 29, 2018PUBLISHED FOR OPPOSITION
Wednesday, May 9, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, April 26, 2018ELECTRONIC RECORD REVIEW COMPLETE
Friday, April 20, 2018ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Thursday, April 12, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, April 12, 2018EXAMINER'S AMENDMENT ENTERED
Thursday, April 12, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, April 12, 2018EXAMINERS AMENDMENT E-MAILED
Thursday, April 12, 2018EXAMINERS AMENDMENT -WRITTEN
Wednesday, April 11, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 11, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 11, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, April 3, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, April 3, 2018NON-FINAL ACTION E-MAILED
Tuesday, April 3, 2018NON-FINAL ACTION WRITTEN
Thursday, February 15, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 15, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 14, 2018ASSIGNED TO LIE
Tuesday, February 6, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, November 28, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, November 28, 2017NON-FINAL ACTION E-MAILED
Tuesday, November 28, 2017NON-FINAL ACTION WRITTEN
Tuesday, November 21, 2017ASSIGNED TO EXAMINER
Friday, August 25, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 24, 2017NEW APPLICATION ENTERED